Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

[Bone metastases treated with radiopharmaceuticals].

Giammarile F.

Bull Cancer. 2013 Nov;100(11):1223-7. Review. French.

PMID:
24409472
2.

Strontium 89 therapy for the palliation of pain due to osseous metastases.

Robinson RG, Preston DF, Schiefelbein M, Baxter KG.

JAMA. 1995 Aug 2;274(5):420-4. Review.

PMID:
7542352
3.

[Radionuclide therapy for painful bone metastases].

Szefer J, Zuchora Z.

Wiad Lek. 2004;57(5-6):280-3. Review. Polish.

PMID:
15518077
4.

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

Kraeber-Bodéré F, Campion L, Rousseau C, Bourdin S, Chatal JF, Resche I.

Eur J Nucl Med. 2000 Oct;27(10):1487-93.

PMID:
11083537
5.

Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.

Pandit-Taskar N, Larson SM, Carrasquillo JA.

J Nucl Med. 2014 Feb;55(2):268-74. doi: 10.2967/jnumed.112.112482. Epub 2013 Dec 16. Review.

6.

[Metabolic radiotherapy: what role will it have in 2001?].

George B, Douard MC, Rain JD.

Cancer Radiother. 2002 May;6(3):188-200. Review. French.

PMID:
12116845
7.

89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.

Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, Sowiński J.

Nucl Med Commun. 2007 Apr;28(4):245-50.

PMID:
17325585
8.

Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.

Rubini G, Nicoletti A, Rubini D, Asabella AN.

Cancer Biother Radiopharm. 2014 Feb;29(1):1-11. doi: 10.1089/cbr.2013.1549. Epub 2013 Nov 1. Review.

PMID:
24180669
9.

[Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].

Badawi JK.

Dtsch Med Wochenschr. 2012 Aug;137(33):1645-9. doi: 10.1055/s-0032-1305201. Epub 2012 Aug 8. Review. German.

PMID:
22875692
10.
11.

Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.

Lee CK, Aeppli DM, Unger J, Boudreau RJ, Levitt SH.

Am J Clin Oncol. 1996 Apr;19(2):102-7.

PMID:
8610630
12.

Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.

Montesano T, Giacomobono S, Acqualagna G, Colandrea M, Di Nicola A, Travascio L, Giancamerla M, D'Apollo R, Toteda M, Ugolini F, Filesi M, Ronga G.

Clin Ter. 2009;160(3):193-9.

PMID:
19756320
13.

Radiation-based approaches for therapy and palliation of advanced prostate cancer.

Lewis B, Sartor O.

Curr Opin Urol. 2012 May;22(3):183-9. doi: 10.1097/MOU.0b013e32835259d2.

PMID:
22453334
14.

Therapy of metastatic bone pain.

Serafini AN.

J Nucl Med. 2001 Jun;42(6):895-906. Review.

15.

Radionuclide therapy and integrated protocols for bone metastases.

Chiacchio S, Mazzarri S, Lorenzoni A, Nyakale N, Boni G, Borsò E, Alsharif A, Grosso M, Manca G, Greco C, Volterrani D, Mariani G.

Q J Nucl Med Mol Imaging. 2011 Aug;55(4):431-47. Review.

PMID:
21738116
16.

A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.

Dafermou A, Colamussi P, Giganti M, Cittanti C, Bestagno M, Piffanelli A.

Eur J Nucl Med. 2001 Jul;28(7):788-98.

PMID:
11504074
17.

Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone.

Porter AT.

Eur Urol. 1994;26 Suppl 1:20-5. Review.

PMID:
7537665
18.

Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.

Piffanelli A, Dafermou A, Giganti M, Colamussi P, Pizzocaro C, Bestagno M; Italian Association of Nuclear Medicine (AINM).

Q J Nucl Med. 2001 Mar;45(1):100-7.

PMID:
11456368
19.

[Targeted radionuclide therapy for castration-resistant prostate cancer].

Nakamura K, Ohga S, Sasaki T, Baba S, Honda H.

Nihon Rinsho. 2014 Dec;72(12):2181-5. Review. Japanese.

PMID:
25518355
20.

(177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study.

Agarwal KK, Singla S, Arora G, Bal C.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):79-88. doi: 10.1007/s00259-014-2862-z. Epub 2014 Jul 29.

PMID:
25070686

Supplemental Content

Support Center